PubMed ID

12668642

UMMS Affiliation

Center for Infectious Disease and Vaccine Research

Date

4-2-2003

Document Type

Article

Subjects

CD8-Positive T-Lymphocytes; Cell Line; *Epitopes, T-Lymphocyte; HLA-A Antigens; Humans; Immunologic Memory; Smallpox Vaccine; T-Lymphocytes, Cytotoxic; Vaccinia virus

Disciplines

Immunology and Infectious Disease

Abstract

Immunization with vaccinia virus resulted in long-lasting protection against smallpox and was the approach used to eliminate natural smallpox infections worldwide. Due to the concern about the potential use of smallpox virus as a bioweapon, smallpox vaccination is currently being reintroduced. Severe complications from vaccination were associated with congenital or acquired T cell deficiencies, but not with congenital agammaglobulinemia, suggesting the importance of T cell immunity in recovery from infection. In this report, we identified two CD8+ T cell epitopes restricted by the most common human major histocompatibility complex (MHC) class I allele, HLA-A*0201. Both epitopes are highly conserved in vaccinia and variola viruses. The frequency of vaccinia-specific CD8+ T cell responses to these epitopes measured by interferon (IFN)-gamma enzyme-linked immunospot (ELISPOT) assay and HLA/peptide tetramer staining peaked 2 wk after primary immunization and then declined, but were still detectable 1 to 3 yr after primary immunization. 2 wk after immunization, IFN-gamma-producing cells specific to these two epitopes were 14% of total vaccinia virus-specific IFN-gamma-producing cells in one donor, 35% in the second donor, and 6% in the third donor. This information will be useful for studies of human T cell memory and for the design and analyses of the immunogenicity of experimental vaccinia vaccines.

Rights and Permissions

Citation: J Exp Med. 2003 Apr 7;197(7):927-32. Epub 2003 Mar 31. Link to article on publisher's site

Related Resources

Link to Article in PubMed